-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, L2dT3LXWzgABWhX68U1/peql6APJ5pEl3K//fviUFqN1+BrIDcUEQz3SaCTBFvig mumTZBfmfq0g1r4lm0+5nA== 0000200406-06-000109.txt : 20061031 0000200406-06-000109.hdr.sgml : 20061031 20060802114729 ACCESSION NUMBER: 0000200406-06-000109 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060802 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 CORRESP 1 filename1.txt August 2, 2006 Mr. Jim B. Rosenberg Senior Assistant Chief Accountant U.S. Securities and Exchange Commission Division of Corporation Finance Washington, DC 20549 Re: Johnson & Johnson Form 10-K for Fiscal Year Ended January 1, 2006 File No. 1-03215 Dear Mr. Rosenberg: On July 25, 2006, in a phone conference with Mr. Mark Brunhofer, we discussed four follow-up requests to our response to your letter of May 31, 2006. The items were as follows: 1. Relocate Schedule II - Valuation and Qualifying Accounts currently included in the Form 10-K to Management's Discussion and Analysis of Results of Operations and Financial Condition in the Annual Report. 2. Disaggregate the accrued rebates, returns and promotions line within Schedule II to three distinct line items. 3. Enhance the disclosure of sales returns allowances within Management's Discussion and Analysis of Results of Operations and Financial Condition. 4. Include an assertion regarding the impact that reasonably likely changes to our assumptions could have on our financial statements. Our response to these items is as follows: 1. We will include Schedule II type disclosure- Valuation and Qualifying Accounts within Management's Discussion and Analysis of Results of Operations and Financial condition beginning with the fiscal year ended December 31, 2006 and for all subsequent year end filings. This schedule will be included by segment for the current year and the prior year. A summary schedule for our three segments of business in the aggregate for the current year and 2 prior years will continue to be included as Schedule II in our Form 10-K. 2. We will disaggregate the accrued rebates, returns and promotions line into three distinct line items in both the segment disclosure within Management's Discussion and Analysis of Results of Operations and Financial Condition and the summary schedule appearing as Schedule II within the Form 10-K. We will include this beginning with the fiscal year ended December 31, 2006 and for all subsequent year end filings. 3. Beginning in our Form 10-K for the fiscal year ended December 31, 2006, the disclosure of sales returns allowances will be enhanced to include the following language: Sales Returns Allowances represent a reserve for products that may be returned due to expiration, destruction in the field, or in specific areas, product recall. The returns reserve is based on historical return trends by product and by market as a percent to gross sales. We will also include the balance of the reserve for sales returns by segment for the current year and prior year end. 4. Beginning in our Form 10-K for the fiscal year ended December 31, 2006, we will include an assertion regarding the impact that reasonably likely changes to our assumptions could have on our financial statements. If you have any questions or comments, please call me at (732) 524-3737 or Phil Savas, Assistant Corporate Controller, Financial Reporting and Analysis at (732) 524- 3566. Sincerely, Stephen J. Cosgrove cc: W. C. Weldon R. J. Darretta S. M. Rosenberg P. A. Savas -----END PRIVACY-ENHANCED MESSAGE-----